Odonate Therapeutics, Inc. ODT
Set alert
1.12 +1.12 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 43.11M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -14.00
- Beta
- 0.45
- Short ratio
- 0.59
- Inst. own
- 65.68%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 4, 2023
- 50-d avg
- 1.39
- 200-d avg
- 2.81
- 1y target
- 4.00
Key statistics
- Market cap
- 43.11M
- Enterprise value
- -47.07M
- Trailing P/E
- 0.00
- Forward P/E
- -14.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.60
- EPS (TTM)
- -2.71
- Beta
- 0.45
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -44.03M
- Total cash
- 95.03M
- Total debt
- 4.85M
- Return on equity
- -86.14%
- Shares outstanding
- 38.49M
- Short % of float
- 2.30%
- 50-day average
- 1.39
- 200-day average
- 2.81
Analyst view
Consensus: hold
Hold
Price target (mean) 4.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy1
- Buy1
- Hold1
- Sell0
- Strong sell0
Next earnings
Jan 4, 2023
Expected Jan 4, 2023. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 4, 2023 | Sep 1, 2022 | 0.00 | — | — | — |
| Nov 10, 2021 | Sep 1, 2021 | 0.00 | — | — | — |
| Jul 27, 2021 | Jun 1, 2021 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 27, 2019 | Empire Asset Management | init | — | Sell |
| Jan 2, 2018 | Goldman Sachs | init | — | Neutral |
| Jan 2, 2018 | Cowen & Co. | init | — | Outperform |
| Jan 2, 2018 | Jefferies | init | — | Buy |
About Odonate Therapeutics, Inc.
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- odonate.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on ODT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BOXER CAPITAL L L C | Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 29, 2020 | 0 |
| DAVIS AARON I | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 29, 2020 | 0 |
| HEARNE MICHAEL S. | Chief Financial Officer | Stock Award(Grant) | Mar 14, 2021 | 15,517,200 |
| JOHNSON CRAIG A | Director | Purchase | Dec 28, 2020 | 3,000 |
| LEMKEY JOHN G | Chief Operating Officer | Stock Award(Grant) | Nov 29, 2020 | 15,242,200 |
| O'CONNELL JOSEPH P | Officer | Stock Award(Grant) | Mar 14, 2021 | 3,610 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Tang Capital Management, LLC | 40.31% | 15,514,566 | 45.15M | Sep 29, 2021 |
| Boxer Capital, LLC | 14.57% | 5,607,086 | 16.32M | Sep 29, 2021 |
| EcoR1 Capital, LLC | 9.68% | 3,727,261 | 10.85M | Sep 29, 2021 |
| Ikarian Capital, LLC | 4.78% | 1,840,631 | 5.36M | Sep 29, 2021 |
| Vanguard Group, Inc. (The) | 2.50% | 962,199 | 2.80M | Sep 29, 2021 |
| Blackrock Inc. | 1.90% | 731,497 | 2.13M | Sep 29, 2021 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.17% | 449,600 | 1.31M | Sep 29, 2021 |
| Vanguard Extended Market Index Fund | 0.83% | 319,901 | 930.91K | Sep 29, 2021 |
| iShares NASDAQ Biotechnology ETF | 0.79% | 305,625 | 938.27K | Oct 30, 2021 |
| Vanguard Horizon Fund-Strategic Small-Cap Equity Fund | 0.42% | 161,720 | 470.61K | Sep 29, 2021 |
| Fidelity Extended Market Index Fund | 0.42% | 160,571 | 492.95K | Oct 30, 2021 |
| Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 0.21% | 81,261 | 281.98K | Aug 30, 2021 |